Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

European Forum on Oncology 2012

3 Dec 2011
Le Plaza, Brussels, Belgium
The Institute of Cancer Policy
Prof Richard Sullivan – Kings College, London, UK
The Institute of Cancer Policy ( Prof Richard Sullivan – Kings College, London, UK )
23 May 2012
The OECI and EurocanPlatform
Prof Wim van Harten – The Netherlands Cancer Institute, Amsterdam
The OECI and EurocanPlatform ( Prof Wim van Harten – The Netherlands Cancer Institute, Amsterdam )
21 May 2012
Problems in the structure of clinical trials
Prof Thomas Tursz – Institut Gustave Roussy, Paris, France
Problems in the structure of clinical trials ( Prof Thomas Tursz – Institut Gustave Roussy, Paris, France )
21 May 2012
Transfer of information through EurocanPlatform
Prof Ulrik Ringborg – Karolinska Institute, Stockholm, Sweden
Transfer of information through EurocanPlatform ( Prof Ulrik Ringborg – Karolinska Institute, Stockholm, Sweden )
21 May 2012
Prognostic biomarkers and next generation genomic sequencing
Prof Stefan Pfister – Cancer Research Centre, Heidelberg, Germany
Prognostic biomarkers and next generation genomic sequencing ( Prof Stefan Pfister – Cancer Research Centre, Heidelberg, Germany )
21 May 2012
Primary and secondary resistance in colorectal cancer
Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy
Primary and secondary resistance in colorectal cancer ( Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy )
21 May 2012
Analysing changes in the pharmaceutical industry
Dr Siegfried Bialojan – Ernst and Young, Germany
Analysing changes in the pharmaceutical industry ( Dr Siegfried Bialojan – Ernst and Young, Germany  )
21 May 2012
Economics of treating patients
Dr Richard Schilsky – University of Chicago, USA
Economics of treating patients ( Dr Richard Schilsky – University of Chicago, USA )
21 May 2012
Heterogeneity of global cancer outcomes
Prof Reinhard Busse – Technische Universitat, Berlin, Germany
Heterogeneity of global cancer outcomes ( Prof Reinhard Busse – Technische Universitat, Berlin, Germany )
18 May 2012
Use of bio-banks in the EurocanPlatform
Prof Peter Riegman – Erasmus Medical Centre, Rotterdam, Netherlands
Use of bio-banks in the EurocanPlatform ( Prof Peter Riegman – Erasmus Medical Centre, Rotterdam, Netherlands )
18 May 2012
Progress of the EurocanPlatform, one year on
Prof Julio Celis – Danish Cancer Center, Copenhagen, Denmark
Progress of the EurocanPlatform, one year on ( Prof Julio Celis – Danish Cancer Center, Copenhagen, Denmark )
18 May 2012
Update on the FP7 TRANSCAN Project
Dr Maria Ferrantini – Istituto Superiore di Sanita, Rome, Italy
Update on the FP7 TRANSCAN Project ( Dr Maria Ferrantini – Istituto Superiore di Sanita, Rome, Italy )
18 May 2012
New approaches to personalised medicine
Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany
New approaches to personalised medicine ( Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany )
18 May 2012
Bringing together the resources of Eastern and Western European institutes
Prof Ioana Neagoe – Institute of Oncology ‘Prof Dr Ion Chiricuta’, Cluj-Napoca, ...
Bringing together the resources of Eastern and Western European institutes ( Prof Ioana Neagoe – Institute of Oncology ‘Prof Dr Ion Chiricuta’, Cluj-Napoca, Romania )
18 May 2012
Goals of the German Consortium for Translational Cancer Research
Dr Hubert Serve – University of Frankfurt, Germany
Goals of the German Consortium for Translational Cancer Research ( Dr Hubert Serve – University of Frankfurt, Germany )
18 May 2012
Innovation in molecular imaging
Prof Hedvig Hricak – Memorial Sloan-Kettering Cancer Center, USA
Innovation in molecular imaging ( Prof Hedvig Hricak – Memorial Sloan-Kettering Cancer Center, USA )
16 May 2012
Advances in radiation oncology
Prof Guy Storme – University of Brussels, Belgium
Advances in radiation oncology (  Prof Guy Storme – University of Brussels, Belgium  )
16 May 2012
EurocanPlatform and the exchange of information
Dr Ged Brady – The Paterson Institute for Cancer Research, Manchester, UK
EurocanPlatform and the exchange of information ( Dr Ged Brady – The Paterson Institute for Cancer Research, Manchester, UK )
16 May 2012
Effects of lifestyle change in cancer patients
Prof Cornelia Ulrich – National Center for Tumor Diseases, Heidelberg, Germany
Effects of lifestyle change in cancer patients ( Prof Cornelia Ulrich – National Center for Tumor Diseases, Heidelberg, Germany )
16 May 2012
Benefits of open European research area
Prof Claudio Lombardo – Organisation of European Cancer Institutes
Benefits of open European research area  ( Prof Claudio Lombardo – Organisation of European Cancer Institutes )
16 May 2012
Improving educational events and courses
Prof Angelo Paradiso – Giovanni Paolo II National Cancer Institute, Bari, Italy
Improving educational events and courses ( Prof Angelo Paradiso – Giovanni Paolo II National Cancer Institute, Bari, Italy )
16 May 2012
EurocanPlatform project update
Prof Anton Berns – The Netherlands Cancer Institute, Amsterdam
EurocanPlatform project update ( Prof Anton Berns – The Netherlands Cancer Institute, Amsterdam  )
16 May 2012